Dental Plaque Global Clinical Trials Review, H2, 2017

2017-07-26
Price :
Published : Jul-2017
No. of Pages : 114

Dental Plaque Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Dental Plaque Global Clinical Trials Review, H2, 2017” provides an overview of Dental Plaque clinical trials scenario. This report provides top line data relating to the clinical trials on Dental Plaque. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Pharmaceutical Product Development LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Pharmaceutical Product Development LLC (PPD) is a contract research organization (CRO), which offers drug discovery, development and lifecycle management services. The company's service portfolio encompasses early development clinical trial services, drug research and development, regulatory support and late-stage clinical trial management, among others. It has expertise in clinical trials in therapy areas including cardiovascular system, central nervous system, dermatology, gastroenterology, hematology, cancer, infectious diseases, ophthalmology, respiratory and endocrine systems, metabolism, rare diseases and urology. PPD's clients include pharmaceutical, biotechnology, medical device, and academic and government organizations. The company has a presence in North America, Sout......
$250

Merial Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Merial Ltd (Merial), a subsidiary of Boehringer Ingelheim GmbH, is an animal healthcare center that produces and markets pharmaceutical products and vaccines. The center offers products for dogs, cats, beef, dairy, equine, and swine to improve their health and performance. It develops specifically formulated products for cats such as flea and tick control, and vaccines for leukemia, rabies and other feline diseases. Merial offers research and development for biologicals drugs and pharmaceuticals vaccines. The center works with various biotechnology companies to develop new products. It serves beef, dairy producers, and veterinarians in the US. Merial is headquartered in Duluth, Georgia, the US. Merial Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides y......
$250

Centogene AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Centogene AG (Centogene) is a provider of genetic testing services. The company offers genetic testing for rare hereditary disorders. It offers whole genome sequencing, whole exome sequencing, biomarker and biochemical testing; prenatal testing, DNA extraction and cell culture services. Centogene provides research programs related to biomarker discovery and utilization, development of new diagnostic techniques, non-interventional and interventional studies. The company also supports clinicians with genetic counseling services and newborn screening. It provides genetic diagnostic testing for rare hereditary diseases. The company operates in Germany, Austria, India and the UAE. Centogene is headquartered in Rostock, Germany. Centogene AG - Pharmaceuticals & Healthcare - Deals a......
$250

Novartis Pharmaceuticals Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG is a developer, manufacturer and distributor of active ingredients, patent protected medicines and treatments for the healthcare industry. The company's products include innovative prescription medicine and drugs, tablets, capsules, indacaterol inhalation powders, injections, combination tablets, and oral solutions. It also provides transdermal systems, subcutaneous injections, oral granules, soft gelatin capsules, and chewable tablets and suspensions, among others. Novartis offers services such as health education, patient assistance services, healthcare solutions, drug discoveries, and research and development services. The company provides its products for various therapeutic areas such as cardiovascular, c......
$250

Ablynx NV (ABLX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Ablynx NV (Ablynx) is a clinical-stage biopharmaceutical company focused on the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Nanobodies are a novel class of antibody-derived therapeutic proteins which possess structural and functional properties of naturally-occurring heavy chain only antibodies. It has advantages of conventional antibodies along with the key features of small molecule drugs. Ablynx develops Nanobodies to treat serious human diseases including acquired thrombotic thrombocytopenic purpura (aTTp), psoriasis, bone disorders, cancer and pulmonary diseases. The company has ongoing research collaborations and significant partnerships with key pharmaceutical companies including Merck, BoehringerIngelheim and Nov......
$250

Massachusetts Institute of Technology – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Massachusetts Institute of Technology (MIT) is a research university that provides contract research and education. The institute offers education in the areas of computer science, biology, aeronautics, mechanical engineering, civil engineering, economics, electrical engineering, literature, architecture, chemistry, mathematics, political science, history, linguistics, nuclear science, physics, and music and theater arts. It conducts research in the fields of neuroscience, humanities, anthropology, cancer, astronomy, oceanography, nuclear science, cognitive science, nanoscience, and nanotechnology. MIT provides services to its students like student information system, academic calendar, libraries, freshman advising, and student disabilities services. The institute offers extracu......
$250

Insys Therapeutics Inc (INSY) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company's flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead product candidate Syndros (dronabinol oral solution) is intendedfor the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in patients with AIDS. Insys uses its proprietary sublingual spray technology to develop its products. The company offers its products to oncologists, pain specialists and supportive care centers. It has operations in the US and offers its products through third party agreements in international markets. Insys is headquartere......
$250

Cognition Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics. The company uses its proprietary biology and chemistry platforms for the development of novel drug targets and disease modifying therapies for the treatment of central nervous system disorders. Its products target the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and can efficiently displace toxic beta amyloid oligomers bound to receptor proteins on brain cells. The company uses screening strategies to identify small molecules capable of blocking the central toxicity of soluble oligomeric proteins. It also conducts clinical trials. CogRx is headquartered in Pittsburgh, Pennsylvania, the US. Cognition Ther......
$250

Oncolys BioPharma Inc (4588) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers, and develops treatments for cancer and infectious diseases. The company imports and exports oncolytic viruses, drugs and medicines, and tumor diagnostic agents. Its pharmaceutical pipeline products include OBP-301, OBP-801, OBP-601, OBP-AI-001 and OBP-AI-002. Oncolys offers diagnostic pipeline such as OBP-401 and OBP-1101. Oncolys research and develops oncolytic virus drugs for infectious diseases, molecular targeted anti-cancer drugs and tumor diagnostic agents. The company also provides consulting services for development of biotechnology drugs. It operates through its offices located in Tokyo, Kobe and Okayama. Oncolys is headquartered in Tokyo, Japan. Oncolys BioPharma Inc (4588) - Pharmaceuticals ......
$250

Panacea Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The company's pipeline products include PAN-301-1, a human aspartyl (asparaginyl) ß-hydroxylase (HAAH) nanoparticle therapeutic vaccine for the treatment of prostate cancer. Panacea also develops preclinical products in serodiagnosis of cancer, monoclonal antibody-based immunotherapy of cancer, immuno-imaging of cancer, and prevention of chemotherapy-induced cognitive impairment and peripheral neuropathy. Panacea is headquartered in Gaithersburg, Maryland, the US. Panacea Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profil......
$250